SATOTERRA Trademark

Trademark Overview

On Friday, June 5, 2020, a trademark application was filed for SATOTERRA with the United States Patent and Trademark Office. The USPTO has given the SATOTERRA trademark a serial number of 79293126. The federal status of this trademark filing is REGISTERED as of Tuesday, April 27, 2021. This trademark is owned by IPSEN PHARMA S.A.S. The SATOTERRA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; providing information relating to medical and scientific research in the field of pharmaceutical products and clinical trials; testing of pharmaceuticals
satoterra

General Information

Serial Number79293126
Word MarkSATOTERRA
Filing DateFriday, June 5, 2020
Status700 - REGISTERED
Status DateTuesday, April 27, 2021
Registration Number6331203
Registration DateTuesday, April 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements

Goods and ServicesConducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; providing information relating to medical and scientific research in the field of pharmaceutical products and clinical trials; testing of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 11, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 20, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, September 5, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 13, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 13, 2021FINAL DISPOSITION PROCESSED
Tuesday, July 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 25, 2020REFUSAL PROCESSED BY IB
Saturday, October 3, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 3, 2020REFUSAL PROCESSED BY MPU
Tuesday, September 15, 2020APPLICATION FILING RECEIPT MAILED
Saturday, September 12, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 11, 2020NON-FINAL ACTION WRITTEN
Friday, September 11, 2020ASSIGNED TO EXAMINER
Friday, September 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 10, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

satoterra trials clinical conducting products pharmaceutical others field testing research pharmaceuticals